Biovica International AB (publ) (BIOVIC-B.ST)

SEK 1.62

(-8.47%)

Long Term Debt Summary of Biovica International AB (publ)

  • Biovica International AB (publ)'s latest annual long term debt in 2023 was 4.29 Million SEK , down -41.18% from previous year.
  • Biovica International AB (publ)'s latest quarterly long term debt in 2024 Q1 was 3.43 Million SEK , down 0.0% from previous quarter.
  • Biovica International AB (publ) reported annual long term debt of 7.3 Million SEK in 2022, down -16.84% from previous year.
  • Biovica International AB (publ) reported annual long term debt of 8.78 Million SEK in 2021, up 840.36% from previous year.
  • Biovica International AB (publ) reported quarterly long term debt of 4.29 Million SEK for 2023 Q4, down -10.54% from previous quarter.
  • Biovica International AB (publ) reported quarterly long term debt of 4.8 Million SEK for 2023 Q3, down -17.8% from previous quarter.

Annual Long Term Debt Chart of Biovica International AB (publ) (2023 - 2013)

Historical Annual Long Term Debt of Biovica International AB (publ) (2023 - 2013)

Year Long Term Debt Long Term Debt Growth
2023 4.29 Million SEK -41.18%
2022 7.3 Million SEK -16.84%
2021 8.78 Million SEK 840.36%
2020 934 Thousand SEK -58.89%
2019 2.27 Million SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK -100.0%
2014 82 Thousand SEK -94.59%
2013 1.51 Million SEK 0.0%

Peer Long Term Debt Comparison of Biovica International AB (publ)

Name Long Term Debt Long Term Debt Difference
Alligator Bioscience AB (publ) 7.51 Million SEK 42.842%
Ziccum AB (publ) 286 Thousand SEK -1402.098%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 2.15 Million SEK -99.628%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK -405.412%
Genovis AB (publ.) 74.8 Million SEK 94.257%
Intervacc AB (publ) 142 Thousand SEK -2925.352%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Active Biotech AB (publ) 3 Million SEK -43.2%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 86.815%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 93.415%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -913.208%
Egetis Therapeutics AB (publ) 103.4 Million SEK 95.845%
Karolinska Development AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -329.6%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 99.543%
Camurus AB (publ) 13.61 Million SEK 68.442%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 82.473%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 844.9 Million SEK 99.492%
Cyxone AB (publ) 74 Thousand SEK -5705.405%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK -199.164%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 86.553%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -3058.824%
SynAct Pharma AB 58 Thousand SEK -7306.897%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -405.412%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK -143.952%
BioInvent International AB (publ) 14.53 Million SEK 70.444%
Alzinova AB (publ) 800 Thousand SEK -437.0%
Oncopeptides AB (publ) 106.48 Million SEK 95.966%
Pila Pharma AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 95.266%
Diamyd Medical AB (publ) 30.67 Million SEK 85.994%
Xbrane Biopharma AB (publ) 112.89 Million SEK 96.195%
Ascelia Pharma AB (publ) 176 Thousand SEK -2340.909%
Diagonal Bio AB (publ) - SEK -Infinity%